BRAINLIFE.ORG





Current Neuro-Oncology




Volume 25 Number 23
15 December 2023




Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 23, 15 December






Nair SM, Sahu A, Prasad A, George AM, Goel A, Gupta T.
Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report.
Indian J Radiol Imaging. 2023 Dec 4;34(2):351-355. doi: 10.1055/s-0043-1777012. PMID: 38549893. Case report. ˍ




Sato Y, Deguchi S, Norose T, Oishi T, Mitsuya K, Sugino T, Akiyama Y, Nagashima T, Urakami K, Shimoda Y, Ohshima K, Hayashi N, Yamaguchi K.
An autopsy case of primary gliosarcoma with multiple extracranial metastases: pathology after administration of bevacizumab and genetic profile.
Nagoya J Med Sci. 2023 Dec 4;85(4):828-835. doi: 10.18999/nagjms.85.4.828. PMID: 38155632. Case report.
ˍ




Gatz SA, Harttrampf AC, Brard C, Bautista F, Andre N, Abbou S, Rubino J, Rondof W, Deloger M, Rübsam M, Marshall LV, Hubschmann D, Nebchi S, Aerts I, Thebaud E, De Carli E, Defachelles AS, Paoletti X, Godin R, Miah K, Mortimer PGS, Vassal G, Geoerger B.
Phase I/II study of the WEE1 inhibitor adavosertib (AZD1775) in combination with carboplatin in children with advanced malignancies: Arm C of the AcSé-SMART trial.
Clin Cancer Res. 2023 Dec 5. doi: 10.1158/1078-0432.CCR-23-2959. PMID: 38051741. Interventional study˰
ˍ




Chen KT, Huang CY, Pai PC, Yang WC, Tseng CK, Tsai HC, Li JC, Chuang CC, Hsu PW, Lee CC, Toh CH, Liu HL, Wei KC.
Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study.
J Neurooncol. 2023 Dec 7. doi: 10.1007/s11060-023-04517-x. PMID: 38060066. Laboratory investigation, Interventional study˰
ˍ




Lee IY, Hanft S, Schulder M, Judy KD, Wong ET, Elder JB, Evans LT, Zuccarello M, Wu J, Aulakh S, Agarwal V, Ramakrishna R, Gill BJ, Quiñones-Hinojosa A, Brennan C, Zacharia BE, Silva Correia CE, Diwanji M, Pennock GK, Scott C, Perez-Olle R, Andrews DW, Boockvar JA.
Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients.
Future Oncol. 2023 Dec 7. doi: 10.2217/fon-2023-0702. PMID: 38060340. Interventional study protocol.
ˍ




Ruan J, Shi Y, Luo P, Li L, Huang J, Chen J, Yang H.
Safety and feasibility of intra-arterial delivery of teniposide to high grade gliomas after blood-brain barrier disruption: a case series.
J Neurointerv Surg. 2023 Dec 7:jnis-2023-021055. doi: 10.1136/jnis-2023-021055. PMID: 38071559. Case report.
ˍ



*

Auffret L, Ajlil Y, Tauziède-Espariat A, Kergrohen T, Puiseux C, Riffaud L, Blouin P, Bertozzi AI, Leblond P, Blomgren K, Froelich S, Picca A, Touat M, Sanson M, Beccaria K, Blauwblomme T, Dangouloff-Ros V, Boddaert N, Varlet P, Debily MA, Grill J, Castel D.
A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation.
Acta Neuropathol. 2023 Dec 8;147(1):2. doi: 10.1007/s00401-023-02651-4. PMID: 38066305. Laboratory investigation.
ˍ




Cherng HR, Sun K, Bentzen S, Armstrong TS, Gondi V, Brown PD, Mehta M, Mishra MV.
Evaluating the Heterogeneity of Hippocampal Avoidant Whole Brain Radiotherapy Treatment Effect: A Secondary Analysis of NRG CC001.
Neuro Oncol. 2023 Dec 9:noad226. doi: 10.1093/neuonc/noad226. PMID: 38069666. Observational study˰
ˍ




Li X, Shao Y, Wang Z, Zhu J.
Risk prediction and treatment assessment in glioma patients using SEER database: a prospective observational study.
BMJ Open. 2023 Dec 9;13(12):e079341∟. doi: 10.1136/bmjopen-2023-079341. PMID: 38070919. Observational study.
ˍ




Takami H, Brown DA, Spear JA, Shinya Y, Burns TC, Clarke MJ, Krauss WE.
Clinical presentation, role of surgery and prognosis in spinal astrocytoma: Cohort study.
World Neurosurg X. 2023 Dec 9;21:100269. doi: 10.1016/j.wnsx.2023.100269. PMID: 38187503. Observational study. ˍ



*

Hadad S, Gupta R, Oberheim Bush NA, Taylor JW, Villanueva-Meyer JE, Young JS, Wu J, Ravindranathan A, Zhang Y, Warrier G, McCoy L, Shai A, Pekmezci M, Perry A, Bollen AW, Phillips JJ, Braunstein SE, Raleigh DR, Theodosopoulos P, Aghi MK, Chang EF, Hervey-Jumper SL, Costello JF, de Groot J, Butowski NA, Clarke JL, Chang SM, Berger MS, Molinaro AM, Solomon DA.
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Acta Neuropathol. 2023
Dec 11;147(1):3. doi: 10.1007/s00401-023-02654-1. PMID: 38079020. Laboratory investigation, Case report. ˍ




Sidaway P.
Tovorafenib effective against low-grade gliomas harbouring BRAF fusions.
Nat Rev Clin Oncol. 2023 Dec 11. doi: 10.1038/s41571-023-00845-z. PMID: 38082106. News˰
ˍ



*

Cha J, Ding EA, Carvalho EM, Fowler A, Aghi MK, Kumar S.
Glioma Cells Secrete Collagen VI to Facilitate Invasion.
bioRxiv [Preprint]. 2023 Dec 12:2023.12.12.571198. doi: 10.1101/2023.12.12.571198. PMID: 38168332. Laboratory investigation. ˍ




Kossmann MRP, Ehret F, Roohani S, Winter SF, Ghadjar P, Acker G, Senger C, Schmid S, Zips D, Kaul D.
Histopathologically confirmed radiation-induced damage of the brain - an in-depth analysis of radiation parameters and spatio-temporal occurrence.
Radiat Oncol. 2023 Dec 12;18(1):198. doi: 10.1186/s13014-023-02385-3. PMID: 38087368. Observational study.
ˍ




Bianconi A, Koumantakis E, Gatto A, Zeppa P, Saaid A, Nico E, Bruno F, Pellerino A, Rizzo F, Junemann CV, Melcarne A, Garbossa D, Dalmasso P, Cofano F.
Effects of Levetiracetam and Lacosamide on survival and seizure control in IDH-wild type glioblastoma during temozolomide plus radiation adjuvant therapy.
Brain Spine. 2023 Dec 14;4:102732. doi: 10.1016/j.bas.2023.102732. PMID: 38510602. Observational study. ˍ




*Pace A, Lombardi G, Villani V, Benincasa D, Abbruzzese C, Cestonaro I, Corrà M, Padovan M, Cerretti G, Caccese M, Silvani A, Gaviani P, Giannarelli D, Ciliberto G, Paggi MG.
Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated MGMT gene promoter: RACTAC, a phase II multicenter trial.
Front Oncol. 2023 Dec 14;13:1320710. doi: 10.3389/fonc.2023.1320710. PMID: 38162492. Interventional study. ˍ




Sharma A, Garg A, Singh M, Sharma MC, Gupta S, Kunhiparambath H, Tripathi M, Kale SS, Bal C.
Metabolic imaging in recurrent gliomas: comparative performance of 18F-FDOPA, 18F-fluorocholine and 18F-FDG PET/CT.
Nucl Med Commun. 2023 Dec 14. doi: 10.1097/MNM.0000000000001795. PMID: 38095139. Observational study˰
ˍ




Willems YCP, Vaassen F, Zegers CML, Postma AA, Jaspers J, Romero AM, Unipan M, Swinnen A, Anten M, Teernstra O, Compter I, van Elmpt W, Eekers DBP.
Anatomical changes in resection cavity during brain radiotherapy.
J Neurooncol. 2023 Dec 14. doi: 10.1007/s11060-023-04505-1. PMID: 38095775. Observational study˰
ˍ




Dai L, Jing Z, Zhu Y, Deng K, Ma L.
Genome-wide analysis of circulating tumor DNA methylation profiles in cerebrospinal fluid: a clinical trial of oncolytic virus for glioblastoma.
Am J Cancer Res. 2023 Dec 15;13(12):5950-5965. PMID: 38187045. Interventional study. ˍ